Assessment of colour vision impairment in male workers exposed to toluene generally above occupational exposure limits

Occupational Medicine

Volumn 48, Issue 3, 1998, Pages 175-180

  Zavalic, M ^a   Mandic, Z ^b   Turk, R ^a   Bogadi Sare, A ^a   Plavec, D ^a   Gomzi, M ^a   Skender, L J ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Colour vision; Lanthony D 15 test; Neurotoxicity; Solvents; Toluene exposure

Indexed keywords

HIPPURIC ACID; TOLUENE;

ADULT; AIR MONITORING; ALCOHOL CONSUMPTION; AMBIENT AIR; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; COLOR VISION; COLOR VISION DEFECT; COLOR VISION TEST; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTOXICITY; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; URINALYSIS;

ADULT; AGE FACTORS; AIR POLLUTANTS, OCCUPATIONAL; ALCOHOL DRINKING; COLOR VISION DEFECTS; HUMANS; MALE; OCCUPATIONAL DISEASES; PRINTING; SMOKING; STATISTICS, NONPARAMETRIC; TOLUENE;

EID: 0031892018     PISSN: 09627480     EISSN: None     Source Type: Journal    
DOI: 10.1093/occmed/48.3.175     Document Type: Article

References (37)

1. World Health Organization. Toluene. Environ Health Criteria 1985; 52: 11.
2. World Health Organization. Toluene. Environ Health Criteria 1985; 52: 15.
3. Mergler D, Blain L. Colour vision impairment among solvent exposed workers. Proceedings. Twelfth International Congress on Occupational Health in the Chemical Industry. Dublin, 10-12 September 1984: 73-90.
4. Blain L, Lagace JP, Mergler D. Sensitivity and specifity of the Lanthony desaturated D-15 panel to assess chromatic discrimination loss among solvent exposed workers. Environ Health 1985; 3: 105-109.
5. Fallas C, Fallas J, Maslard P, Dally S. Subclinical impairment of colour vision among workers exposed to styrene. Br J Ind Med 1992; 49: 679-682.
6. Gobba F, Gallasi C, Imbriani M, Ghitori S, Candela S, Cavalleri A. Acquired dyschromatopsia among styrene-exposed workers. J Occup Med 1992; 33: 761-765.
7. Mergler D, Belanger S, de Grosbois S, Vachon N. Chromal focus of acquired chromatic discrimination loss and solvent exposure among printshop workers. Toxicol 1988; 49: 341-348.
8. Mergler D, Blain L. Assessing color vision loss among solvent-exposed workers. Am J Ind Med 1987; 12: 195-203.
9. Heran J, Kurt TL, Landrigan PJ, Melius JM, Singal M. Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane(BHMH): A new occupational neuropathy. Am J Publ Health 1985; 75: 513-517.
10. Grant WM. The peripheral visual system as a target. In: Schaumberg HH, Spencer P, eds. Neurotoxicology. London, UK: Williams and Williams, 1992: 77-91.
11. Mergler D, Blain L, Lagace JP. Solvent related colour vision loss: an indicator of neural damage? Ind Arch Occup Environ Health 1987; 59: 313-321.
12. Roth MA. Le test 28-hur selon Farnsworth. Bull Soc Opthalmol de France 1966; 66: 237-238.
13. Ruddock KH. The effect of age upon color vision. I. Response to the receptoral system of the human eye. Vision Res 1965; 5: 37-45.
14. Russell RM, Carney EA, Feiock K, Garrett M, Karwoski P. Acute ethanol administration causes transient impairment of blue-yellow vision. Alcoholism Clin Exp Res 1980; 4: 396-399.
15. Dubois-Poulsen A. Acquired dyschromatopsia. Mod Prob Opthalmol 1972; 11: 84-93.
16. Verriest F. On acquired deficiency of colour vision with special reference to its detection and classification by means of the test of Farnsworth. Vision Res 1961; 1: 201-219.
17. Nakatsuka H, Watanabe T, Takeuchi, et al. Absence of blue-yellow color vision loss among workers exposed to toluene or tetrachloroethylene, mostly at levels below occupational exposure limits. Int Arch Occup Environ Health 1992; 64: 113-117.
18. Zavalic M, Turk R, Bogadi-Sare A, Skender LJ. Colour vision impairment in workers exposed to low concentration of toluene. Arh Hig Rada Toksikol 1995; 47: 199-209.
19. Lanthony P, Dubois-Poulsen A. Le Farnsworth 15 desature. Bull Soc Ophtal Francais 1973; 73: 862-866.
20. Blain L, Mergler D. La dyschromatopsie chez les personnes exposes professionnellement aux solvants organiques. J Fr Ophtalmol 1986; 9: 127-133.
21. Lanthony P. The desaturated panel D-15. Doc Opthal 1978; 46: 185-189.
22. Pinckers A, Nabbe B, Boddard P. Le test 15 hue desature de Lanthony. Ann Occult 1976; 209: 731-738.
23. Hart WM. Acquired dyschromatopsias. Sur Ophtalmol 1987; 32: 10-28.
24. Hobley A, Lawrenson J. Ocular adverse effect to the therapeutic administration of digoxin. Opthalmic Physiol Opt 1991; 11: 391-393.
25. Mantyjavri M. Screening of diabetics who read incorrectly colour-dependent glucose test-strips. Doc Opthalmol 1992; 80: 323-328.
26. Schaumburg HH, Spencer PS. Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science 1978; 199: 199-200.
27. National Institute for Occupational Safety and Health. Criteria for a recommended standard occupational exposure to benzene. New Publication 1974; 74-137.
28. Angerer J, Szadovski D, Manz A, Pett R, Lehnert G. Chronische Losungsmittelbelastung am Arbeitsplatz. I. Gaschromatographische Bestimmung von Benzol und Toluol in der Luft und im Damfraum von Blutproben. Int Arch Arbeitsmed 1973; 31: 1-8.
29. Nise G. Urinary excretion of o-cresol and hippuric acid after toluene exposure in rotogravure printing. Int Arch Occup Environ Health 1992; 63: 377-381.
30. Nise G, Orback P. Toluene in venous blood during and after work in rotogravure printing. Int Arch Occup Environ Health 1988; 60: 31-35.
31. Bowman KJ, Colins MJ, Henry CJ. The effect of age on the Panel D-15 and Desaturated D-15: A quantitative evaluation. Doc Proc Opthalmol Ser 1984; 39: 227-231.
32. Verriest G, Franq P, Pierant P. Results of color vision tests in alcoholic and mentally disordered subjects. Ophthalmology 1980; 180: 247-256.
33. Thielly P. Alkoholismus und Invaliditet. Off Gesundh-Wesen 1981; 43: 152-153.
34. Brinkman GL, Coates EO. The effect of bronchitis, smoking and occupation on ventilation. Am Rev Resp Dis 1963; 87: 684-693.
35. Campagna D, Mergler D, Huel G, Belanger S, Truchon G, Ostiguy C, Drolet D. Visual dysfunction among sryrene-exposed workers. Scan J Work Environ Health 1995; 21: 382-390.
36. Mutti A, Franchini I. Toxicity of metabolites to dopaminergic system and the behavioural effects of organic solvents. Br J Ind Med 1987; 44: 721-723.
37. Mergler D, Huel G, Belanger S, Bowler RM, Truchon G, Drolet D, Ostiguy C. Surveillance of early neurotoxic dysfunction. Neurotoxicol 1996; 17(3-4): 803-812.